Interpharm Holdings, Inc. (IPAH)
Interpharm Holdings, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Hauppauge, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $660. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -18.6%. Its beta of -1.65 implies it has historically moved less than the broad market.
Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.
Interpharm Holdings, Inc. is most often compared with the following Healthcare names: